In Brief This Week: Becton Dickinson, Corning; Empire Genomics; Emergent Technologies; Octa Phillip Bioscience Managers | GenomeWeb

NEW YORK (GenomeWeb News) – Becton Dickinson this week completed the sale of its Discovery Labware business to Corning for approximately $720 million in cash. The sale excludes BD's Advanced Bioprocessing platform.


Empire Genomics has opened a new clinical lab facility at its headquarters on the Buffalo Niagara Medical Campus in upstate New York and expects to create more than 50 new jobs within the next five years. The firm also introduced this week its multiple myeloma test for aiding physicians in therapeutic guidance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.